A detailed history of Tidemark, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Tidemark, LLC holds 1,121 shares of DXCM stock, worth $99,522. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,121
Previous 1,721 34.86%
Holding current value
$99,522
Previous $115,000 24.35%
% of portfolio
0.03%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

SELL
$65.68 - $81.01 $39,408 - $48,606
-600 Reduced 34.86%
1,121 $87,000
Q3 2024

Nov 07, 2024

BUY
$64.0 - $116.06 $4,672 - $8,472
73 Added 4.43%
1,721 $115,000
Q4 2023

Feb 09, 2024

BUY
$75.49 - $124.16 $124,407 - $204,615
1,648 New
1,648 $205 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $34.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Tidemark, LLC Portfolio

Follow Tidemark, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tidemark, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tidemark, LLC with notifications on news.